产品特点
Revised: July 2011
AN: 00150/2011
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Norotril Max 100 mg/ml Solution for Injection for Cattle (all other CMS)
Enrotril Max 100 mg/ml Solution for Injection for Cattle (Ireland and Portugal)
Enrotril 100 mg/ml Solution for Injection for Cattle (Germany, Italy and Spain)
Enrofloxacin N-vet (Sweden)
Respytril 100 mg/ml Solution for Injection for Cattle (France)
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH ML CONTAINS:
ACTIVE SUBSTANCE
Enrofloxacin
100.0 mg
EXCIPIENTS
Benzyl alcohol (E1519)
20.0 mg
butan-1-o1
30.0 mg
For full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Solution for injection.
Clear yellow solution.
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Indicated for the treatment of bovine respiratory disease associated with
_Mannheimia haemolytica,_ _Pasteurella multocida, Histophilus somni_ and
_Mycoplasma_ spp. where clinical experience, supported where possible by
sensitivity testing of the causal organism, indicates enrofloxacin as the drug of
choice.
Revised: July 2011
AN: 00150/2011
Page 2 of 6
4.3 CONTRAINDICATIONS
The product should not be used for prophylaxis
Do not use in case of disturbances in growth of cartilage and/or during injury of
locomotory system particularly on functionally loaded joints or due to body weight
loaded joints.
4.4
阅读完整的文件